PC Nopoulos, AL Conrad, EF Bell… - Archives of Pediatrics …, 2011 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better. ... Add to CiteULike Add to Connotea Add to Delicious ... Cited by 1 - Related articles - All 3 versions
SM Devine, S Carter, RJ Soiffer, MC Pasquini… - Biology of Blood and …, 2011 - Elsevier Graft versus host disease (GVHD) is most effectively prevented by ex vivo T cell depletion (TCD) of the allograft but its role in the treatment of patients undergoing allogeneic hematopoietic cell transplantation (HCT) for acute myeloid leukemia (AML) in complete remission (CR) ... Cited by 2 - Related articles - All 3 versions
[PDF] from hematologylibrary.orgMED Flowers, Y Inamoto… - …, 2011 - bloodjournal.hematologylibrary.org ... Correspondence: Mary ED Flowers, MD, Fred Hutchinson Cancer Research Center ... Key words: hematopoietic cell transplantation, chronic graft-versus-host disease, acute ...Blood First Edition Paper, prepublished online January 26, 2011; DOI 10.1182/blood-2010-08-302109 ... Cited by 3 - Related articles - All 2 versions
CA Keever-Taylor, SM Devine, RJ Soiffer… - Biology of Blood and …, 2011 - Elsevier Eight centers participated in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303 to determine the effect of extensive T-cell depletion (TCD) on the outcome of HLA matched sibling donor transplant for acute myeloid leukemia. One goal of the ...